Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ziakas, Panayiotis D ^a   Thapa, Rachana ^a   Rice, Louis B ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIUM CULTURE; ENTEROCOCCAL INFECTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; TREND STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIAL INFECTIONS; CROSS INFECTION; ENTEROCOCCUS; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84884683600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075658     Document Type: Article

References (72)

1. Sandiumenge A, Rello J, (2012) Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 18: 187-193. doi:10.1097/MCP.0b013e328351f974. PubMed: 22366995.
2. Doyle JS, Buising KL, Thursky KA, Worth LJ, Richards MJ, (2011) Epidemiology of infections acquired in intensive care units. Semin Respir Crit Care Med 32: 115-138. doi:10.1055/s-0031-1275525. PubMed: 21506049.
3. Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, et al. (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Update 14: 118-124. doi:10.1016/j.drup.2011.02.003. PubMed: 21435939.
4. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, et al. (2012) The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect.
5. Ramsey AM, Zilberberg MD, (2009) Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 30: 184-186. doi:10.1086/593956. PubMed: 19125679.
6. Salgado CD, (2008) The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control 36S175:: e175-e178.
7. Padiglione AA, Grabsch EA, Olden D, Hellard M, Sinclair MI, et al. (2000) Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis 6: 534-536. doi:10.3201/eid0605.000514. PubMed: 11202974.
8. Song JY, Hwang IS, Eom JS, Cheong HJ, Bae WK, et al. (2005) Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med 20: 55-62. doi:10.3904/kjim.2005.20.1.55. PubMed: 15906954.
9. Lin MY, Hayden MK, (2010) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units. Crit Care Med 38: S335-S344. doi:10.1097/CCM.0b013e3181b4a334. PubMed: 20647791.
10. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, et al. (2006) Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol 27: 1068-1075. doi:10.1086/507960. PubMed: 17006814.
11. Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, et al. (2003) Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 47: 2492-2498. doi:10.1128/AAC.47.8.2492-2498.2003. PubMed: 12878510.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535 doi:10.1136/bmj.b2535. PubMed: 19622551.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140. doi:10.1016/0196-6553(88)90053-3. PubMed: 2841893.
14. Horan TC, Andrus M, Dudeck MA, (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36: 309-332. doi:10.1016/j.ajic.2008.03.002. PubMed: 18538699.
15. Saha S, Chant D, Welham J, McGrath J, (2005) A systematic review of the prevalence of schizophrenia. PLOS Med 2: e141. doi:10.1371/journal.pmed.0020141. PubMed: 15916472.
16. Fazel S, Khosla V, Doll H, Geddes J, (2008) The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLOS Med 5: e225. doi:10.1371/journal.pmed.0050225. PubMed: 19053169.
17. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
18. Rücker G, Schwarzer G, Carpenter JR, Schumacher M, (2008) Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 8: 79. doi:10.1186/1471-2288-8-79. PubMed: 19036172.
19. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
20. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463. doi:10.1111/j.0006-341X.2000.00455.x. PubMed: 10877304.
21. Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, et al. (2001) Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". Clin Infect Dis 33: 1654-1660. doi:10.1086/323762. PubMed: 11595985.
22. Mascini EM, Jalink KP, Kamp-Hopmans TE, Blok HE, Verhoef J, et al. (2003) Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type. J Clin Microbiol 41: 5377-5383. doi:10.1128/JCM.41.12.5377-5383.2003. PubMed: 14662914.
23. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM, (1999) Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 96: 6908-6913. doi:10.1073/pnas.96.12.6908. PubMed: 10359812.
24. Bonten MJ, Hayden MK, Nathan C, van Voorhis J, Matushek M, et al. (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348: 1615-1619. doi:10.1016/S0140-6736(96)02331-8. PubMed: 8961991.
25. Bonten MJ, Slaughter S, Hayden MK, Nathan C, van Voorhis J, et al. (1998) External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 26: 2001-2004. doi:10.1097/00003246-199812000-00029. PubMed: 9875911.
26. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, et al. (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368: 533-542. doi:10.1056/NEJMoa1113849. PubMed: 23388005.
27. Batistão DW, Gontijo-Filho PP, Conceição N, Oliveira AG, Ribas RM, (2012) Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz 107: 57-63. doi:10.1590/S0074-02762012000100008. PubMed: 22310536.
28. Grabsch EA, Mahony AA, Cameron DR, Martin RD, Heland M, et al. (2012) Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. J Hosp Infect 82: 234-242. doi:10.1016/j.jhin.2012.08.010. PubMed: 23103245.
29. Kim YJ, Kim SI, Kim YR, Lee JY, Park YJ, et al. (2012) Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am J Infect Control 40: 1018-1019. doi:10.1016/j.ajic.2012.01.009. PubMed: 22483236.
30. Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, et al. (2012) Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLOS ONE 7: e47297. doi:10.1371/journal.pone.0047297. PubMed: 23071778.
31. Yoon YK, Kim HJ, Lee WJ, Lee SE, Yang KS, et al. (2012) Clinical prediction rule for identifying patients with vancomycin-resistant enterococci (VRE) at the time of admission to the intensive care unit in a low VRE prevalence setting. J Antimicrob Chemother 67: 2963-2969. doi:10.1093/jac/dks303. PubMed: 22888271.
32. Huang SS, Datta R, Rifas-Shiman S, Kleinman K, Placzek H, et al. (2011) Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study. Crit Care 15: R210. doi:10.1186/cc9630. PubMed: 21914221.
33. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, et al. (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364: 1407-1418. doi:10.1056/NEJMoa1000373. PubMed: 21488763.
34. Minhas P, Perl TM, Carroll KC, Shepard JW, Shangraw KA, et al. (2011) Risk factors for positive admission surveillance cultures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in a neurocritical care unit. Crit Care Med 39: 2322-2329. doi:10.1097/CCM.0b013e3182227222. PubMed: 21705905.
35. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, et al. (2009) The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 37: 1858-1865. doi:10.1097/CCM.0b013e31819ffe6d. PubMed: 19384220.
36. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, et al. (2009) Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control 37: 734-740. doi:10.1016/j.ajic.2008.09.025. PubMed: 19188004.
37. Wibbenmeyer L, Appelgate D, Williams I, Light T, Latenser B, et al. (2009) Effectiveness of universal screening for vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus on admission to a burn-trauma step-down unit. J Burn Care Res 30: 648-656. doi:10.1097/BCR.0b013e3181abff7e. PubMed: 19506499.
38. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, et al. (2008) Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 29: 709-715. doi:10.1086/589582. PubMed: 18631116.
39. Lambiase A, Del Pezzo M, Piazza O, Petagna C, De Luca C, et al. (2007) Typing of vancomycin-resistant Enterococcus faecium strains in a cohort of patients in an Italian intensive care Unit. Infection 35: 428-433. doi:10.1007/s15010-007-6288-4. PubMed: 18034209.
40. Littvik AM, López TN, González SE, Fernández CM, Pavan JV, (2006) Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Córdoba City, Argentina. Rev Argent Microbiol 38: 28-30. PubMed: 16784130.
41. Peta M, Carretto E, Barbarini D, Zamperoni A, Carnevale L, et al. (2006) Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect 12: 163-169. doi:10.1111/j.1469-0691.2005.01331.x. PubMed: 16441455.
42. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, et al. (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166: 306-312. doi:10.1001/archinte.166.3.306. PubMed: 16476870.
43. Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, et al. (2005) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 11: 1539-1544. doi:10.3201/eid1110.050508. PubMed: 16318693.
44. Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, et al. (2004) Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 25: 105-108. doi:10.1086/502358. PubMed: 14994933.
45. Winston LG, Charlebois ED, Pang S, Bangsberg DR, Perdreau-Remington F, et al. (2004) Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control 32: 462-469. doi:10.1016/j.ajic.2004.07.004. PubMed: 15573053.
46. Yeh KM, Siu LK, Chang JC, Chang FY, (2004) Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units. Microb Drug Resist 10: 177-183. doi:10.1089/1076629041310091. PubMed: 15256034.
47. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, et al. (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362: 1011-1016. doi:10.1016/S0140-6736(03)14409-1. PubMed: 14522530.
48. Ho PL,. (2003) Hong Kong intensive care unit antimicrobial resistance study G (2003) Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 31: 1175-1182. doi:10.1097/01.CCM.0000059437.01924.97. PubMed: 12682490.
49. Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR, (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163: 1905-1912. doi:10.1001/archinte.163.16.1905. PubMed: 12963563.
50. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ, (2003) The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 24: 257-263. doi:10.1086/502199. PubMed: 12725354.
51. Gardiner D, Murphey S, Ossman E, Jungkind D, (2002) Prevalence and acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Infect Control Hosp Epidemiol 23: 466-468. doi:10.1086/502087. PubMed: 12186214.
52. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM, (2002) To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 35: 18-25. doi:10.1086/340739. PubMed: 12060870.
53. Hendrix CW, Hammond JM, Swoboda SM, Merz WG, Harrington SM, et al. (2001) Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg 233: 259-265. doi:10.1097/00000658-200102000-00016. PubMed: 11176133.
54. Marín ME, Podestá O, Llambías P, Galdón F, Scilingo VM, et al. (2001) Detection of carriage of vancomycin-resistant enterococci in an intensive care unit in Buenos Aires. Infect Control Hosp Epidemiol 22: 332-333. doi:10.1086/503402. PubMed: 11519907.
55. Dan M, Poch F, Leibson L, Smetana S, Priel I, (1999) Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect 43: 231-238. doi:10.1053/jhin.1998.0641. PubMed: 10582190.
56. Grayson ML, Grabsch EA, Johnson PD, Olden D, Aberline M, et al. (1999) Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 171: 133-136. PubMed: 10474604.
57. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, et al. (1999) Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 159: 1467-1472. doi:10.1001/archinte.159.13.1467. PubMed: 10399898.
58. Zuckerman RA, Steele L, Venezia RA, Tobin EH, (1999) Undetected vancomycin-resistant Enterococcus in surgical intensive care unit patients. Infect Control Hosp Epidemiol 20: 685-686. doi:10.1086/501565. PubMed: 10530646.
59. Slaughter S, Hayden MK, Nathan C, Hu TC, Rice T, et al. (1996) A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 125: 448-456. doi:10.7326/0003-4819-125-6-199609150-00004. PubMed: 8779456.
60. Pogorzelska M, Stone PW, Larson EL, (2012) Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections. Am J Infect Control 40: 96-101. doi:10.1016/j.ajic.2011.10.002. PubMed: 22381222.
61. Borg MA, Camilleri L, Waisfisz B, (2012) Understanding the epidemiology of MRSA in Europe: do we need to think outside the box? J Hosp Infect 81: 251-256. doi:10.1016/j.jhin.2012.05.001. PubMed: 22695171.
62. Top J, Willems R, Bonten M, (2008) Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 52: 297-308. doi:10.1111/j.1348-0421.2008.00039.x. PubMed: 18279340.
63. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, et al. (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13([MedlinePgn:]) PubMed: 19021959.
64. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011. doi:10.1086/591861. PubMed: 18947320.
65. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P, (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14: R113. doi:10.1186/cc8345. PubMed: 20546564.
66. Bourdon N, Fines-Guyon M, Thiolet JM, Maugat S, Coignard B, et al. (2011) Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J Antimicrob Chemother 66: 713-721. doi:10.1093/jac/dkq524. PubMed: 21393182.
67. Safdar N, Maki DG, (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136: 834-844. doi:10.7326/0003-4819-136-11-200206040-00013. PubMed: 12044132.
68. Olivier CN, Blake RK, Steed LL, Salgado CD, (2008) Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 29: 404-409. doi:10.1086/587647. PubMed: 18419361.
69. Patel R, Allen SL, Manahan JM, Wright AJ, Krom RA, et al. (2001) Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 7: 27-31. doi:10.1053/jlts.2001.20784. PubMed: 11150418.
70. Matar MJ, Tarrand J, Raad I, Rolston KV, (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34: 534-536. doi:10.1016/j.ajic.2006.04.205. PubMed: 17015161.
71. Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, et al. (2007) Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 13: 615-621. doi:10.1016/j.bbmt.2007.01.078. PubMed: 17448922.
72. Tschudin Sutter S, Frei R, Dangel M, Gratwohl A, Bonten M, et al. (2010) Not all patients with vancomycin-resistant enterococci need to be isolated. Clin Infect Dis 51: 678-683. doi:10.1086/655824. PubMed: 20687839.